Cancer Research 1985-12-01

Comparative metabolic activation in mouse skin of the weak carcinogen 6-methylchrysene and the strong carcinogen 5-methylchrysene.

S Amin, K Huie, A A Melikian, J M Leszczynska, S S Hecht

Index: Cancer Res. 45(12 Pt 1) , 6406-42, (1985)

Full Text: HTML

Abstract

We compared the metabolic activation in mouse skin of the weak carcinogen 6-methylchrysene, which lacks a bay region methyl group, and the strong carcinogen 5-methylchrysene, which has a bay region methyl group. Metabolites of 6-methyl-chrysene were prepared using liver homogenates and were identified by their spectral properties and by comparison to synthetic standards as dihydrodiols, hydroxymethyl derivatives, and phenols; their relative levels of formation in liver homogenates from rats and mice were dependent on inducer pretreatment. In mouse skin in vivo, the major metabolite of 6-methyl-chrysene was trans-1,2-dihydro-1,2-dihydroxy-6-methylchrysene (6-MeC-1,2-diol), the precursor to a bay region dihydrodiol epoxide. Its concentration was greater than that of trans-1,2-dihydro-1,2-dihydroxy-5-methylchrysene (5-MeC-1,2-diol) formed in mouse skin from 5-methylchrysene. Since 5-MeC-1,2-diol has been identified as a major proximate carcinogen of 5-methylchrysene, the further metabolism and tumorigenicity of 5-MeC-1,2-diol and 6-MeC-1,2-diol were compared. Both dihydrodiols were converted to 1,2,3,4-tetraols and to 1,2-dihydroxy metabolites to similar extents in mouse skin. However, 5-MeC-1,2-diol was significantly more active than was 6-MeC-1,2-diol as a tumor initiator on mouse skin. The formation of DNA adducts in mouse skin from 5-methylchrysene and 6-methylchrysene was compared. Both hydrocarbons gave qualitatively similar adduct patterns, but the formation of dihydrodiol epoxide type adducts was 1/20 as great from 6-methylchrysene as from 5-methylchrysene. The results of this study indicate that the weak tumorigenicity of 6-methylchrysene compared to that of 5-methylchrysene is not due to differing rates of formation or further metabolism of their 1,2-dihydrodiols but is a likely consequence of the lower activity of 1,2-dihydroxy-3,4-epoxy-1,2,3,4-tetrahydro-6-methylchrysene compared to 1,2-dihydroxy-3,4-epoxy-1,2,3,4-tetrahydro-5-methylchrysene; the unique structural feature of the latter is the presence of a methyl group and an epoxide ring in the same bay region.


Related Compounds

  • 6-Methylchrysene

Related Articles:

Metabolism of chrysene, 5-methylchrysene, 6-methylchrysene and 5,6-dimethylchrysene in rat liver cytosol, in vitro, and in rat subcutaneous tissue, in vivo.

1991-01-01

[Chem. Biol. Interact. 77(2) , 203-21, (1991)]

Enhancing effect of a bay region methyl group on tumorigenicity in newborn mice and mouse skin of enantiomeric bay region diol epoxides formed stereoselectively from methylchrysenes in mouse epidermis.

1987-10-15

[Cancer Res. 47(20) , 5310-5, (1987)]

Effects of methylated chrysenes on AhR-dependent and -independent toxic events in rat liver epithelial cells.

2008-05-21

[Toxicology 247(2-3) , 93-101, (2008)]

High stereoselectivity in mouse skin metabolic activation of methylchrysenes to tumorigenic dihydrodiols.

1987-07-15

[Cancer Res. 47(14) , 3613-7, (1987)]

Metabolism of 5-methylchrysene and 6-methylchrysene by human hepatic and pulmonary cytochrome P450 enzymes.

1996-01-15

[Cancer Res. 56(2) , 316-24, (1996)]

More Articles...